Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
Clinical trial NCT00051636 · COMPLETED
Trial details
- NCT number
- NCT00051636
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2004-03-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.